Loeb Partners Corp’s Bristol-Myers Squibb BMY Stock Holding History

Loeb Partners Corp’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-1,300	Closed	-$62K	–	21
2019 Q1	$62K	Sell	1,300 -260	-17%	-$13K	1.27%	18
2018 Q4	$81K	Buy	+1,560	New	+$83.8K	0.04%	149
2018 Q3	–	Sell	-3,960	Closed	-$219K	–	148
2018 Q2	$219K	Buy	+3,960	New	+$214K	0.06%	150
2016 Q2	–	Sell	-63,710	Closed	-$4.07M	–	168
2016 Q1	$4.07M	Hold	63,710	–	–	1.45%	21
2015 Q4	$4.38M	Buy	63,710 +3,640	+6%	+$241K	1.4%	19
2015 Q3	$3.56M	Sell	60,070 -8,440	-12%	-$535K	1.31%	20
2015 Q2	$4.56M	Buy	68,510 +13,900	+25%	+$916K	1.32%	19
2015 Q1	$3.52M	Sell	54,610 -32,000	-37%	-$2M	1.03%	26
2014 Q4	$5.11M	Sell	86,610 -100	-0.1%	-$5.64K	1.52%	16
2014 Q3	$4.44M	Sell	86,710 -3,000	-3%	-$150K	1.47%	17
2014 Q2	$4.35M	Hold	89,710	–	–	1.32%	22
2014 Q1	$4.66M	Buy	89,710 +78,900	+730%	+$4.2M	1.56%	15
2013 Q4	$575K	Hold	10,810	–	–	0.18%	114
2013 Q3	$500K	Hold	10,810	–	–	0.17%	114
2013 Q2	$483K	Buy	+10,810	New	+$469K	0.18%	109

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Loeb Partners Corp's BMY Position: Q2 2019 in Review

Loeb Partners Corp sold out of Bristol-Myers Squibb (BMY) in Q2 2019, closing a stake of 1,300 shares — an estimated $62K sold.

Loeb Partners Corp first reported a position in BMY in Q2 2013 and held it in 15 quarters. The position peaked at $5.11M in Q4 2014. 1,777 funds tracked by Wall St. Rank hold BMY as of Q2 2019.

Loeb Partners Corp reported no remaining Bristol-Myers Squibb position as of Q2 2019 after selling out during the quarter.
Loeb Partners Corp sold 1,300 Bristol-Myers Squibb shares in Q2 2019, an estimated $62K.
Loeb Partners Corp first reported a position in Bristol-Myers Squibb in Q2 2013 and held it in 15 quarters.
Loeb Partners Corp's Bristol-Myers Squibb position peaked at $5.11M in Q4 2014.
1,777 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2019.

Based on Loeb Partners Corp's 13F filing for Q2 2019.